Prognostic Role of the Platelet-to-Lymphocyte Ratio for Patients With Metastatic Colorectal Cancer Treated With Aflibercept

Conclusion: A low pretreatment PLR might be a predictor of aflibercept efficacy in patients with mCRC and may be clinically useful for selecting patient responders.

Source: In Vivo - August 30, 2020 Category: Research Authors: MATSUDA, A., YAMADA, T., MATSUMOTO, S., SHINJI, S., OHTA, R., SONODA, H., SHINOZUKA, E., SEKIGUCHI, K., SUZUKI, H., YOSHIDA, H. Tags: Clinical Studies Source Type: research